Denmark vs Thailand: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Denmark
0.1%
in 2024
Thailand
0.1%
in 2024
Denmark rank
112th
Thailand rank
112th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Denmark
- Thailand
How they compare
Denmark currently reports 0.1% against 0.1% in Thailand, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Denmark ahead.
Denmark ranks 112th and Thailand ranks 112th of 215 countries.
Denmark has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Denmark | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | Denmark |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Denmark or Thailand?
- Denmark, at 0.1% against 0.1% in Thailand as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Denmark and Thailand?
- 0.0%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Thailand?
- 10 years are reported by both, from 2015 to 2024.
- How do Denmark and Thailand rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Denmark ranks 112th and Thailand ranks 112th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.